World Health Assembly panel to shine light on global pervasiveness of uncorrected refractive error
May 24th 2024Representatives from CooperVision and the International Agency for the Prevention of Blindness give a preview of what to expect at the "Universal Access to Glasses: Promoting Multisectoral Action" event at this year's World Health Assembly in Geneva, Switzerland.
Ocugen announces dosing completion in second cohort of GARDian clinical trial for Stargardt disease
May 20th 2024The trial evaluates OCU410ST, a modifier gene therapy candidate utilizing an AAV delivery platform for the retinal delivery of the RORA gene. The gene therapy is being designed as a one-time treatment for life.